MICROBIOTA E CHEMIOTERAPIA: EFFICACIA O TOSSICITA’ ? UNA SPLENDIDA REVIEW DALL’IMPERIAL COLLEGE DI LONDRA. DA “GASTROENTEROLOGY” (FREE).

EPATOLOGIA ONCOLOGICA, GASTROENTEROLOGIA, MEDICINA DEI PROBIOTICI, ONCOLOGIA, PANCREAS E VIE BILIARI, Senza categoriaLascia un commento

Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy Despoina Chrysostomou et al. Accumulating evidence supports not only the functional role of the gut microbiome in cancer development and progression but also its role in defining the efficacy and toxicity of chemotherapeutic agents (5-fluorouracil, cyclophosphamide, irinotecan, oxaliplatin, gemcitabine, methotrexate) and immunotherapeutic compounds…

LINEE GUIDA PER LA MALATTIA CELIACA 2023. DA “AMERICAN JOURNAL OF GASTROENTEROLOGY” (FREE).

DISPEPSIA, GASTROENTEROLOGIA, LINEE GUIDA EBM, MEDICI DI FAMIGLIA, MEDICINA INTERNA, Senza categoriaLascia un commento

American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease Rubio-Tapia, Alberto et al. Abstract This guideline presents an update to the 2013 American College of Gastroenterology Guideline on the Diagnosis and Management of Celiac Disease with updated recommendations for the evaluation and management of patients with celiac disease (CD). CD is defined…

MICROBIOTA E DISORDINI DELL’UMORE. UNA MAGNIFICA REVIEW E META-ANALISI. DA “CURRENT OPINION IN PSYCHIATRY”.

MEDICINA DEI PROBIOTICI, MEDICINA INTERNA, NUTRIZIONE, Senza categoriaLascia un commento

Advances in the gut microbiome and mood disorders Mörkl, Sabrina et al. Abstract Purpose of review The gut microbiome is in constant bidirectional communication with the brain through the microbiota-gut-brain-axis. Mood disorders are among the most common psychiatric disorders and include major depressive disorder and bipolar disorder. The gut microbiome is altered in individuals with…

MICROBIOTA E BRAIN-GUT AXIS. UNA INTERVISTA CON IL GRANDE SPECIALISTA JOHN F.CRYAN. DA “FEBS JOURNAL” (FREE)

MEDICINA DEI PROBIOTICI, MEDICINA INTERNA, Senza categoriaLascia un commento

In conversation with John Cryan Paraminder Dhillon and John F. Cryan Abstract John F. Cryan is Chair of the Department of Anatomy and Neuroscience, Principal Investigator in the APC Microbiome Ireland Institute and Vice President for Research and Innovation at University College of Cork, Ireland. He obtained his bachelor’s and doctoral degrees (in Biochemistry and…

LA GESTIONE DELLA METAPLASIA GASTRICA INTESTINALE. RILEGGETE GENTE, RILEGGETE! DA”GASTROENTEROLOGY” (FREE)

ENDOSCOPIA, GASTROENTEROLOGIA, MEDICI DI FAMIGLIA, MEDICINA INTERNA, ONCOLOGIA, Senza categoriaLascia un commento

Histologic Subtyping of Gastric Intestinal Metaplasia: Overview and Considerations for Clinical Practice Shailja C. Shah et al Gastric cancer remains the third leading cause of cancer-related mortality and the fifth most common cancer worldwide, responsible for an estimated 1 million new cases and more than 780,000 deaths in 2018 alone.1 Gastric adenocarcinoma is the most…

COME IMMETTERE NELLE REVIEW E NELLE META-ANALISI GLI STUDI NON-RANDOMIZZATI. LE NUOVE LINEE GUIDA DALLA AGENZIA AMERICANA PER LA HEALTH CARE RESEARCH. DA”JCE” (FREE).

METODOLOGIA, REAL WORLD EVIDENCE, Senza categoriaLascia un commento

Inclusion of nonrandomized studies of interventions in systematic reviews of interventions: updated guidance from the Agency for Health Care Research and Quality Effective Health Care program Ian J. Saldanha et al. Abstract Objectives We developed guidance to inform decisions regarding the inclusion of nonrandomized studies of interventions (NRSIs) in systematic reviews (SRs) of the effects…